Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effects of Biologic Therapy With Disease Activity and Circadian Rhythm

Trial Profile

The Effects of Biologic Therapy With Disease Activity and Circadian Rhythm

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jan 2019

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 30 Jun 2019.
    • 31 Aug 2018 Biomarkers information updated
    • 07 Jul 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top